Coronado looks at ophthalmic acquisitions:
This article was originally published in Clinica
Executive Summary
US ophthalmic company Coronado Industries is looking at various medical product lines for acquisition to assist in its revenue stream pending FDA approval for its pneumatic glaucoma treatment device. The company is already selling its low cost pneumatic trabeculoplasty (PNT) device in Europe, through its wholly owned subsidiaries, American Glaucoma and Ophthalmic International. It claims that PNT is a non-invasive cost-effective procedure compared to traditional treatments. Coronado, of Fountain Hills, Arizona will license the device in the US upon FDA approval.